MiRNA-based therapy for glucose intolerance and insulin resistance: The oncomiR miR-17-92 promotes ß-cell mass and function via down regulation of its target gene, 20/May/2014, 7.47 am

MiRNA-based therapy for glucose intolerance and insulin resistance: The oncomiR miR-17-92 promotes ß-cell mass and function via down regulation of its target gene, 20/May/2014, 7.47 am

MiRNA-based therapy for glucose intolerance and insulin resistance: The oncomiR miR-17-92 promotes ß-cell mass and function via down regulation of its target gene, 20/May/2014, 7.47 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, MiRNA-based therapy for glucose intolerance and insulin resistance: The oncomiR miR-17-92 promotes ß-cell mass and function via down regulation of its target gene, 20/May/2014, 7.47 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing